Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1 | 1 | 1 | 1 | 1 |
| Accounts receivable | -7 | 3 | 8 | 14 | -33 |
| Accounts payable and accrued liabilities | 206 | -231 | 303 | -5 | 126 |
| Other Working Capital | 190 | -127 | 290 | 127 | 185 |
| Other Operating Activity | -1,527 | -1,408 | -2,497 | -2,010 | -1,629 |
| Operating Cash Flow | $-1,136 | $-1,762 | $-1,895 | $-1,873 | $-1,350 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 381 | 1,568 | 186 | 94 | N/A |
| Other Financing Activity | 472 | -402 | -72 | 182 | 5,270 |
| Financing Cash Flow | $853 | $1,166 | $115 | $276 | $5,270 |
| Beginning Cash Position | 1,195 | 1,790 | 3,602 | 5,175 | 1,279 |
| End Cash Position | 942 | 1,195 | 1,754 | 3,602 | 5,175 |
| Net Cash Flow | $-283 | $-595 | $-1,780 | $-1,596 | $3,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,136 | -1,762 | -1,895 | -1,873 | -1,350 |
| Free Cash Flow | -1,136 | -1,762 | -1,895 | -1,873 | -1,350 |